William A. Heyburn
CIK 1859732 · Co-CEO and CFO · last filed 2026-09-25
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
BLDEW price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
31 HUDSON YARDS, 14TH FLOOR
NEW YORK, NY 10001
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SRTA | Co-CEO and CFO | 1,856,206 | $4.44 | $8.24M | -$185.9K | 5 | 2026-09-25 |
| Strata Critical Medical, Inc. (SRTAW) Delisted | Co-CEO and CFO | 1,882,399 | $0.00 | $1.1K | $76.0K | 6 | 2026-04-27 |
| Strata Critical Medical, Inc. (BLDEW) Delisted | Chief Financial Officer | 1,463,940 | $0.18 | $262.6K | -$2.41M | 35 | 2025-08-05 |
Recent Filings · Page 4 of 6
54 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-03-15 | Strata Critical Medical, Inc. (BLDEW) Delisted | Mixed | −28,842 | -$140.6K | EDGAR |
| 2024-03-13 | SRTA | Notice (144) | −60,741 | -$143.5K | EDGAR |
| 2024-03-12 | Strata Critical Medical, Inc. (BLDEW) Delisted | Grant (A) | +20,552 | $0 | EDGAR |
| 2024-01-03 | Strata Critical Medical, Inc. (BLDEW) Delisted | Exer (M) | +57,686 | $10.4K | EDGAR |
| 2023-12-15 | Strata Critical Medical, Inc. (BLDEW) Delisted | Sell (S) | −37,374 | -$116.1K | EDGAR |
| 2023-12-13 | SRTA | Notice (144) | −46,080 | -$115.9K | EDGAR |
| 2023-10-06 | Strata Critical Medical, Inc. (BLDEW) Delisted | Sell (S) | −39,127 | -$95.5K | EDGAR |
| 2023-10-04 | SRTA | Notice (144) | −42,910 | -$91.5K | EDGAR |
| 2023-07-19 | Strata Critical Medical, Inc. (BLDEW) Delisted | Exer (M) | +33,712 | $6.1K | EDGAR |
| 2023-07-10 | Strata Critical Medical, Inc. (BLDEW) Delisted | Sell (S) | −83,797 | -$320.5K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.